Clinical Trials
7 trialsNCT07593872 2026-05-18
XR-NeckLND
National Taiwan University Hospital
Phase NA Not yet recruiting
NCT07538193 2026-04-20
Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer
Tang-Du Hospital
Phase NA Not yet recruiting
NCT06252129 2026-03-05
Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens
Brigham and Women's Hospital
Phase NA Recruiting
NCT07162883 2025-09-09
Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)
Qilu Pharmaceutical Co., Ltd.
Phase 3 Not yet recruiting
NCT04233476 2024-07-01
TRIIL
RDO Pharm.
Phase 3 Completed
NCT06031246 2023-09-11
Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)
Fudan University
Phase 3 Recruiting
NCT02341170 2019-04-17
HIPPO-S
Universitätsmedizin Mannheim
Phase NA Withdrawn